Abstract
Nowadays, modern approaches in tissue engineering include the combination of therapeutic relevant cells with high quality, biocompatible biomaterials. The resulting cellularized scaffolds are of great interest for several pharmaceutical applications such as drug screening/discovery, disease modeling, and toxicity testing. In addition, the introduction of human-induced pluripotent stem cells (hiPSCs) further increased the importance and the potential of tissue engineering not only for the pharmaceutical industry, but also for future therapeutic applications. Artificial microenvironments of hiPSCs comprise combinations of adhesive proteins and are particularly influenced by mechanical properties of the growth surface. The increasing focus on mechanical properties and the ability to adjust them propose alginate hydrogels as suitable candidates for engineered scaffolds. Ultra-pure alginates, however, are bioinert and require modifications for bioactivation. In this study, we present two modifications of alginate hydrogels based on direct covalent coupling of collagen I and coupling of a special linker molecule with subsequent Matrigel coating. We were able to demonstrate the successful adhesion and proliferation of hiPSCs on these linker-modified alginates. The developed modifications are particularly applicable for planar as well as spherical hydrogel surfaces. In this context, a scalable adherent suspension culture on alginate microcarriers could be established. Our data further indicate that larger alginate microcarriers modified with collagen I is less susceptible for agglomeration compared to small microcarriers. The obtained results indicate these modifications as suitable for both adhesion and cultivation of human stem cells such as human mesenchymal stem cells or hiPSCs.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The combination of promising therapeutically relevant cell lines with natural or synthetic biomaterials in the rapidly developing field of tissue engineering serves a common strategy for the generation of high valuable cell-based models (Fig. 1a) for both disease modeling (Prestwich 2007) and drug screening/discovery (Kimlin et al. 2013). In particular, knowledge gained from the cell-matrix interaction can be transferred to novel approaches in regenerative medicine such as cartilage repair (Re’em et al. 2010).
The used biomaterial represents more than a supporting “scaffold”: it provides tissue- or cell-specific signals for proper functionality of the whole construct concerning, e.g., adhesion sites, cavities, chemical gradients, or elastic surfaces (Ghaemi et al. 2013; Gattazzo et al. 2014) and simultaneously influences the fate (see Fig. 1b) of human stem cells (Watt and Huck 2013). Due to this complexity, a rational design in a screening-like manner has not been conducted in the past, except for empirical “tissue try this” approaches (Kaplan et al. 2005; Ingber et al. 2006). Furthermore, surfaces coated by combinatorial proteins as well as the inclusion of compliant properties play key roles during the design of artificial cellular environments (Discher et al. 2005; Buxboim et al. 2010). The direct influence of the elastic modulus of the surface has been demonstrated in several studies by both changes in morphology and the analysis of comprehensive gene expression studies (Engler et al. 2006). After decades of cell cultivation on stiff polystyrene surfaces, new scientific questions consequently arise concerning the interaction of cells with their mechanical surrounding, and thus, the complexity in designing artificial cellular environments increases. Since the introduction of human-induced pluripotent stem cells (hiPSCs), the demand for novel innovative, bioactive, and xeno-free surfaces for cultivation and differentiation workflows is continuously growing (Saha et al. 2011; de Peppo and Marolt 2013; Fan et al. 2014).
After the first description and generation of these cells (Takahashi and Yamanaka 2006; Takahashi et al. 2007), the scientific community is confronted with entirely new possibilities. Derived from somatic cells, such as fibroblasts from skin biopsies, hiPSCs can be reprogrammed by a defined set of genetic factors. Since these cells have a similar potential as human embryonic stem cells with less ethical concerns (Murphy et al. 2013), they can virtually be differentiated into each specialized cell of the human body (Lee et al. 2010; Lancaster and Knoblich 2014; Kempf et al. 2015). Furthermore, hiPSCs can be generated from patients with genetic disorders, and thus, the corresponding cells can be used for patient-specific drug testing (Gunaseeli et al. 2010; Ebert et al. 2012). In this context, compliant bioactive hydrogels can enhance both the current workflows during differentiation and the subsequent generated cell models.
One of the most promising candidates for engineering compliant in vivo-like surfaces are alginate hydrogels (Fig. 1c–e). Alginates can be isolated from brown algae and are unbranched polymers consisting of homogeneous or heterogeneous blocks of β-d-mannuronic or α-l-guluronic acids (Draget et al. 2005). Protocols for the extraction of xeno-free, ultra-pure, high molecular weight alginates are available (Zimmermann et al. 2005; Fertah et al. 2014). The composition of the polymers, however, depends on the choice of algae species (Smidsrød and Skjåk-Bræk 1990), environmental conditions (Storz et al. 2009), or individual parts of the algae (stipe, leaf) (Dalheim et al. 2016). The gelation of alginate solutions occurs by ionotropic gelation under gentle conditions (Malpique et al. 2010) using divalent cations like Ca2+ or Ba2+ (Smidsrød and Skjåk-Bræk 1990). Since the alginate gelation can be conducted at physiological pH and temperatures, it is therefore particularly suited for applications in regenerative medicine and tissue engineering (Mettler et al. 2013). So far, alginates have been studied intensively in the context of immunoisolation of therapeutically relevant cells owing to development of novel approaches for treatment of diabetes mellitus (Duvivier-Kali et al. 2001; Schneider et al. 2005; Neufeld et al. 2013). Here, cells are encapsulated in a protective alginate shell, which can be implanted for therapeutic approaches. Due to the porosity of the alginate hydrogel, a bidirectional mass transfer of, e.g., oxygen, nutrients, metabolites, and active compounds from the inner of the alginate-capsule and vice versa, is still possible. For such an application, a bioinert material for the encapsulation is crucial to support long-term survival of the enclosed cells (Ponce et al. 2006). Crude alginates can lead to an immune response or to fibrosis, potentially inducing a loss of the transplant (van Schilfgaarde and de Vos 1999).
At the same time, such purified alginates are not suitable in terms of adherent cultivation of anchorage-dependent cells (Jeong et al. 2010) and only irregular surface characteristics (scratches) can lead to an cell adhesion of (rather simple) cell types such as fibroblasts (Zimmermann et al. 2007b). Machida-Sano et al. studied cell adhesion of alginates cross-linked with different cations and concluded that the protein adsorption on the hydrogel surface is one crucial factor for cell adhesion (Machida-Sano et al. 2009, 2014). Due to the hydrophilic properties of alginate hydrogels, low protein adsorption is expected. In this context, the usage of alginate surfaces for multipotent and especially for pluripotent stem cells is highly challenging. Pluripotent stem cells require a specialized cellular environment for adhesion guaranteeing survival (Chen et al. 2010; Kurosawa 2012) and maintaining/losing their identity (Sheridan et al. 2012). Bioactivation of alginate hydrogels by mixing proteins and polysaccharides is challenging due to complex chemical interactions of these macromolecules (Rodríguez Patino and Pilosof 2011). In addition, a transfer to spherical hydrogels is difficult regarding a proper presentation of the proteins at the surface (Terazono et al. 2012). Non-covalent mixing of these components for bioactivation represents a more suitable strategy for complete cell encapsulation in hydrogels (Sang et al. 2011). Furthermore, defined stem cell culture media do not provide any proteins that can adsorb on the alginate’s surface and trigger cell adhesion (Fadeev and Melkoumian 2011). In order to cultivate human stem cells successfully on alginate hydrogels, it is essential to modify the polymers for engineering suitable stem cell environments.
Advanced specialized cultivation surfaces represent so-called microcarriers. Microcarriers are a valuable tool for cultivation of anchorage-dependent cells in static hanging droplet cultures or suspension cultures like stirred bioreactors. This cultivation method is increasingly important, since the production of the required high cell amounts is not possible using 2D cultivation systems. There is a high demand for novel innovative cell expansion substrates in large biorepositories such as the European Bank for induced pluripotent Stem Cells (EBiSC, www.ebisc.org). Thereby, the advantages of homogeneous cultivation conditions (e.g., no chemical gradients) can be applied to adherent cell lines with an excellent surface-to-volume ratio.
Microcarriers, introduced for the first time in 1967 (Van Wezel 1967), can be described as solid, porous, or macroporous with densities between 0.9 and 1.32 g mL−1 (Chen et al. 2013). The diameters of microcarriers vary from 120 to 300 μm (Kong et al. 1999; Chen et al. 2013; Goh et al. 2013). In addition, microcarriers are functionalized with different surface features like charge or protein coatings. Common materials used for commercial microcarrier production are DEAE-dextran, cellulose, polystyrene, alginate, glass, or gelatin and allow the efficient cultivation with extremely high surface-to-volume ratio (Kong et al. 1999; Asthana and Kisaalita 2012; Chen et al. 2013; Goh et al. 2013). Despite the great success of these microcarriers, there is still a high demand for adoptable microcarrier systems in terms of mechanical properties, size, and biochemical functionalization. In our opinion, microcarriers based on ultra-high-viscosity (UHV)-alginate hydrogels can provide several of the posed demands due to their unique and partially adjustable properties. They can be adjusted concerning diameter, stiffness, porosity, surface properties, and the functionalization of the microcarrier’s core by bioactive molecules such as growth factors. The functionalization of the surface accessible for the attachment of cells can be induced with proteins like collagen, fibronectin, or vitronectin.
In this study, we investigated the specific functionalization of cross-linked alginate surfaces in order to immobilize proteins with bioactive, cell-recognizable motifs triggering cell adhesion. We studied two different ways of bioactivation: one direct method by coupling proteins and one universal, indirect approach for adsorption of complex protein mixtures on the alginate’s surface. The generated surfaces have been evaluated with two promising human stem cell types/lines: human mesenchymal stem cells (hMSCs) and hiPSCs. In consequence, our study provides a basis for future research on sophisticated cell models or transplants for regenerative medicine, disease modeling, or drug screening/discovery.
Materials and methods
Seaweed-derived alginates
In this study, we used alginates from the brown algae Lessonia nigrescens (LN) and Lessonia trabeculata (LT) procured in dry state from Alginatec GmbH, Riedenheim, Germany. The two species differ in chemical composition (mannuronic/guluronic acid ratio) and thus in the final mechanical properties of the hydrogel after cross-linking. Raw materials were cleaned, peeled, chopped, and dried under controlled conditions immediately after harvest to minimize contamination. The extraction of alginates was conducted under sterile conditions. Purification of the alginate extract was by sterile filtration and a series of subsequent precipitations in ethanol and re-solution in potassium chloride solution. The final purified alginate was dried and stored at +4 °C until usage. A detailed description of the production of purified ultra-high viscous alginates is given by Zimmermann et al. ( 2005). The purified alginate is suitable for long-term cultivation of human cells (Schneider et al. 2005). For hydrogel formation, alginate granulates were dissolved in isotonic sodium chloride solution (Sigma) and mixed until complete solvation. Both alginate types were prepared separately as 0.7% (w%/v%) solutions and mixed in equal parts before usage.
Cell culture of hMSCs
Human mesenchymal stem cells (hMSCs, PromoCell GmbH, Heidelberg, Germany) were cultured and expanded in DMEM/F-12 (Gibco) containing 10% fetal bovine serum, 100 U mL−1 penicillin/streptomycin (Gibco), and 1 ng mL−1 basic fibroblast growth factor (bFGF, Gibco). Cells were passaged using trypsin/EDTA (0.05%, Gibco) once a week or at a confluency of 80%.
Cell culture of hiPSC
hiPSCs AXAi (Axiogenesis AG, Germany) were delivered by the manufacturer in cell culture flasks with a growth area of 175 cm2 and cultured until usage. Cells were expanded in “AX-IP-N8” cell culture medium provided by the manufacturer and exchanged at regular intervals. For experiments, cells were washed with DMEM/F-12 (Gibco), detached using TrypLE (Gibco), and dispersed in cell culture medium. The resulting single cell suspension was supplemented with ROCK inhibitor (Cayman Chemical) in order to avoid apoptosis.
Alginate membrane modified with collagen I
Cell culture dishes (Corning, cell culture treated, diameter 35 mm) were treated with poly-l-lysine (Sigma, 1:10 dilution (v%/v%) in phosphate-buffered saline) for 30 min at 37 °C. In order to provide positive charges to mediate alginate adhesion on the polystyrene surface, the solution was aspirated and the surface air-dried. Subsequently, 1 mL of alginate solution (0.7%, w%/v%) was poured into the Petri dish and cross-linked for 15 min with 1 mL BaCl2 solution (20 mM) at room temperature. The cross-linking of alginate solution was conducted using a 20 mM BaCl2 solution with 115 mM NaCl and 5 mM l-histidine (all chemicals from Sigma). Next, cross-linking solution was aspirated and alginate surfaces were washed three times to remove excessive barium. Afterwards, the alginate membranes were activated (see Fig. 2a) by aqueous carbodiimide chemistry (adopted from (Rowley et al. 1999)), containing N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC, 200 mM, Sigma) and N-hydroxysuccinimide (NHS, 50 mM, Sigma) in aqua bidest for 30 min at room temperature. Subsequently, the beads were washed twice with aqua bidest. After activation, the membranes were incubated in different dilutions of collagen I (0, 7.5, 37.5, and 75 μg mL−1, from rat tail, Gibco, diluted in 1 mL 0.1 M HEPES, pH 5.2, 0.1 osmol) overnight at room temperature (see Fig. 2b). The membranes were washed twice in 0.9% NaCl. hMSCs (6250 cells per cm2) were inoculated in 2 mL culture medium, observed, and cultivated for 8 h in automated microscopes (Biostation IM, Nikon). The number of attached cells (% of total cells seeded) was quantified manually 1 h after inoculation.
Alginate microcarriers modified with collagen I
For the production of alginate microcarriers, alginate beads were produced by coaxial air jet technology (Zimmermann et al. 2005, 2007a). A 1:1 (v%/v%) mixture of LN and LT alginate was prepared, and alginate spheres were generated by dropping the alginate into a barium chloride gelation bath (containing 20 mM BaCl2, 115 mM NaCl, and 5 mM l-histidine). In addition, small alginate spheres (approx. 200 μm diameter) and large alginate spheres (approx. 600–700 μm) were produced. To remove excessive gelating agents, the spheres were washed in NaCl (0.9%, w%/v%). In this form, alginate hydrogels are bioinert and no integrin-mediated adhesion of cells is triggered by physicochemical properties of the alginate spheres’ surface. Hence, the alginate beads were activated by aqueous carbodiimide chemistry (adopted from (Rowley et al. 1999)) according to the former paragraph (see Fig. 2a, b). Subsequently, the beads were washed twice with aqua bidest. After activation, the beads were incubated in a 10 mL solution with 7.5 μg mL−1 collagen I (from rat tail, Gibco, diluted in 0.1 M HEPES, pH 5.2, 0.1 osmol) overnight at room temperature. The produced alginate microcarriers were washed twice in 0.9% NaCl and stored at 4 °C until usage and before cell seeding.
Stirred microcarrier culture of hMSCs in mini-bioreactors
For the cultivation of hMSCs, we used a suspension bioreactor system (BioLevitator, Hamilton Bonaduz AG, Switzerland) with four parallelized bioreactors (Levitubes, Hamilton Bonaduz AG, Switzerland). The parameters used for inoculation were 50-rpm rotation speed, 5-s rotation period, 2-s rotation pause, 2-min agitation period, and 10-min agitation pause for an overall duration of 4 h. After inoculation, the cultivation was started with 60-rpm rotation speed, 5-s rotation period, and 3-s rotation pause for an overall duration of 7 days. We cultivated hMSCs on four different microcarrier systems: Cytodex 1 precoated with collagen I, Cytodex 3 (Sigma-Aldrich, Germany), and our two developed alginate microcarrier systems with different sizes as described earlier. The total growth area per condition was adjusted to 72 cm2. Suspensions of cells and microcarriers were inoculated at a density of 4000 cells per square centimeter in 40 mL culture medium. This proportion was the same for all types of microcarriers in the used suspension bioreactors. Half of the culture medium was exchanged once a week. For subsequent analysis, microscopic images were captured during the inoculation phase (1, 2, and 3 h) as well as after 1, 3, 6, and 7 days. The distribution of the cells during the inoculation phase and the distribution of cell-microcarrier aggregates were determined manually. The confluent cell areas on microcarriers were determined manually after day 6.
Alginate membranes modified with a linker and coated with Matrigel
Two alginate membranes in 60-mm Petri dishes (Nunc) were produced as described earlier. Alginate membranes were activated for 30 min at room temperature using 200 mM EDC and 50 mM NHS (see above, Fig. 2a). A solution of extracellular matrix proteins was prepared solving 1 mg Matrigel (Corning) in 12 mL DMEM/F-12 (Beers et al. 2012) and poured onto the activated alginate surface. In addition, a sterile solution of 0.1 g mL−1 of the solution with the linker molecule was prepared with 0.1 mM HEPES (Sigma, 0.1 mM, pH 5.2) and poured onto the second activated alginate surface. Both preparations were incubated overnight at room temperature. Subsequently, samples were thoroughly rinsed with isotonic NaCl solution and DMEM/F-12. The alginate surface with directly coupled Matrigel (A-MG) was stored at 37 °C until usage (Fig. 2c). Again, a solution of 1 mg in 12 mL DMEM/F-12 was prepared and poured onto a standard tissue culture polystyrene surface (Nunc) (T-MG) and on alginate surfaces modified with the linker (A-LKR-MG). Both preparations were incubated overnight at 37 °C. Before cell inoculation, the preparations were washed with DMEM/F-12 and sterilized for 15 min with UV light.
hiPSC culture on bioactive alginate surfaces
hiPSCs AXAi were inoculated (12,000 cells cm−2) and cultivated over 6 days. After 24 h the medium was exchanged and adherent cells were quantified (Millipore Scepter). After 6 days the cells were harvested and the cell number was determined.
Statistics
The data are presented as mean ± standard deviation (SD) from three independent biological experiments. Data analysis was performed using OriginPro 2015b (OriginLab) for Microsoft Windows.
Results
Production of bioactive alginate surfaces
After long-time experience with the production of ultra-pure “clinical-grade” alginates (Jork et al. 2000; Zimmermann et al. 2005) and extensive studies on alginate hydrogels in the context of immunoisolation of pancreatic cells, we focused on the specific bioactivation of alginate hydrogels for applications in tissue engineering. Early approaches with ultra-high viscous alginate surfaces were conducted with highly concentrated collagen I solution and used a pH shift for non-covalent coating (Gröhn et al. 1997). These approaches could approve cell adhesion, but only in such cell systems with minimal requirements to their immediate microenvironment attached and spread (Gröhn et al. 1997). In this study, we investigated the specific modification of alginate hydrogels towards a bioactive surface for attachment and cultivation of human stem cells. We analyzed two principles of cell culture: adherent cultivation on planar hydrogels, as well as adherent suspension culture on spherical hydrogels that are in strong demand by industrial biotechnology, e.g., for large-scale production of therapeutics (Liu et al. 2007). The proposed protocol for alginate hydrogel modification is compatible with both systems and can be finalized within 1 or 2 days. During the modification steps, changed wettability of planar surfaces or increased “stickiness” of the spherical hydrogels on the reaction tubes was observed indicating changed chemical properties. The successful modification was evaluated by assessing cellular response in subsequent adhesion experiments with human stem cells.
Cultivation and expansion of hMSCs on planar bioactive alginate surfaces
The initial experiments with collagen I bioactive alginate surfaces revealed, on the one hand, the functionality of the modification protocol for ultra-high viscous alginates and, on the other hand, the relatively fast cell reaction in terms of adhesion and spreading of cells. We coupled several amounts of collagen I onto the alginate’s surface and measured the attached cell number (% of cells seeded) after 1 h (Fig. 3a). The unmodified, native alginate surface allowed no cell adhesion; cells remained round and without membrane extrusions in suspension (Fig. 3b). After coupling of 7.5 μg to the alginate’s surface, first positive reactions could be observed (Fig. 3c). Cells start to attach and achieved an overall attachment rate of 56.7% (±42.8%). The relatively high standard deviation results from one experiment with no cell adhesion. In summary, the reproducibility of this small protein concentration is critical in terms of stable modification workflows. At higher concentrations, we observed both excellent cell adhesion behavior after 1 h and excellent reproducibility. At 37.5 μg (Fig. 3d), 95.5% (±3.3%) cells attached and spread. At 75 μg (Fig. 3e), 91.4% (±8.5%) of the cells attached and spread. Overall, our data demonstrate the possibility of both stable bioactivation and a very fast cell attachment. Especially for non-static applications, such as an adherent suspension culture on microcarriers, a fast interaction is necessary for efficient cell inoculation of microcarriers. The fast cell adhesion on spherical alginate microcarrier is illustrated in Fig. 4a.
Cultivation and expansion of hMSCs on spherical bioactive alginate surfaces
The cultivation of multipotent hMSCs on different microcarrier systems revealed the ability to use novel UHV-based alginate microcarriers for cultivation and expansion of cells in both static hanging droplet cultures and in suspension bioreactor systems. While Cytodex 1, Cytodex 3, and small UHV-alginate microcarriers showed a tendency to build large cell-microcarrier agglomerates (Fig. 4c), large UHV-alginate microcarriers remained mainly as single microcarrier systems (see Fig. 4b). The cell attachment on microcarriers was quantified during the inoculation phase, since the attachment of cells during this phase is crucial for further efficient cultivation and expansion (Frauenschuh et al. 2007). The mean cell number on Cytodex 1 was 3.3 ± 1.5, 3.6 ± 1.4, and 4.2 ± 1.7 after 1, 2 and 3 h, respectively. The mean cell number on Cytodex 3 was 2.7 ± 1.4, 3.6 ± 1.9, and 3.6 ± 2.0 after 1, 2 and 3 h. respectively. Small UHV-alginate microcarriers revealed a mean cell number of 4.0 ± 2.6, 6.0 ± 4.0, and 7.7 ± 5.3 after 1, 2, and 3 h, respectively. Large UHV-alginate microcarriers demonstrated the highest cell numbers per microcarrier with 7.8 ± 3.8, 9.0 ± 4.6, and 10.5 ± 4.5 after 1, 2, and 3 h, respectively (Fig. 4d).
The populated microcarriers cultivated in a rotating bioreactor were analyzed after 1 week concerning their tendency of agglomeration (Fig. 4e). According to the number of involved microcarriers, we divided the agglomerated microcarriers into five classes (1, 2, 3, 4, and more than four agglomerated microcarriers). The distribution was as follows (order 1, 2, 3, 4, and more ± SD): 98.3 ± 2.9, 1.7 ± 2.9, 0.0 ± 0.0, 0.0 ± 0.0, and 0.0 ± 0.0% for big alginate microcarriers. The distribution of small alginate microcarriers was 35.0 ± 21.8, 11.7 ± 2.9, 11.7 ± 7.6, 10.0 ± 10.0, and 31.7 ± 12.6%. In comparison, the distribution of Cytodex 1 microcarriers referred to 31.7 ± 33.3, 16.7 ± 2.9, 18.3 ± 12.6, 8.3 ± 5.8, and 25.0 ± 17.3% and for Cytodex 3 20.0 ± 15.0, 16.7 ± 12.6, 20.0 ± 8.7, 8.3 ± 2.9, and 35.0 ± 30.4%. The distribution revealed a comparable behavior of agglomeration of small alginate, Cytodex 1, and Cytodex 3 microcarriers, if cultivated in a rotating bioreactor. In consequence, our data indicate that the large alginate microcarriers show a completely different behavior according to agglomeration with the used parameters. The vast majority of populated microcarriers did not agglomerate. After day 6, the expansion (proliferation) of hMSCs was investigated by measuring the confluency (proportion of surface covered with cells). The confluency was used as a parameter for cell proliferation (Curl et al. 2004) since we were also confronted with low yields using enzymatic detachment of cells as it is reported by other research groups (Weber et al. 2007; Rafiq et al. 2013; Nienow et al. 2016). The analysis of optimal cell detachment protocols from alginate microcarriers will consequently be part of subsequent studies. The most microcarriers, however, were overgrown in the range of 75–100% (Fig. 4f) independent from the type of microcarrier. Overall, comparable confluency results were observed for all microcarrier types.
Cultivation and expansion of hiPSCs on planar bioactive alginate surfaces
After inoculating a single cell suspension of hiPSCs on TCPS-coated Matrigel (T-MG, Fig. 5a), alginate directly modified with Matrigel (A-MG, Fig. 5b), and alginate modified with the linker molecule and coated with Matrigel (A-LKR-MG, Fig. 5c), a fast cell response was observed on T-MG and A-LKR-MG surfaces. Cells attached and spread within 1 h. Since longer resting time in suspension might trigger apoptosis (Krawetz et al. 2009), this fact is essential. Furthermore, cells started to form colonies with close cell-cell contacts, the typical arrangement of these cells. On alginate, cells barely attach on the alginate’s surface and remain still in suspension. After 24 h, the lowest number of attached cells was measured on A-MG (58.0 ± 15.6%), whereas the number of attached cells was comparable between T-MG (81.7 ± 13.9%) and A-LKR-MG (77.1 ± 15.0%, Fig. 5d). A continuous proliferation of cells was observed during the experiments on T-MG as well as on A-LKR-MG surfaces. The end-point analysis (Fig. 5e) showed 38.3-fold (±5.8) increase on T-MG surfaces and 11.2-fold (±9.0) increase on T-LKR-MG surfaces. In contrast, cells on A-MG obtained a 0.9-fold (±0.7) decrease.
Discussion
Chemical modification of alginate hydrogels
In this study, we established a stable protocol for covalent coupling of amide-containing molecules onto carboxyl groups of barium cross-linked alginates. Although introduced by Rowley et al. (1999) more than 15 years ago, an approach that utilizes a linker molecule for universal coating of alginates was still missing. Our ongoing experimental work also revealed that further therapeutically relevant cell types such as hiPSCs-derived cardiomyocytes are able to adhere and contract on these bioactive hydrogels (data not shown). First indications of mechanical interaction in terms of compression or deformation of hMSCs with the alginate have been observed during our experiments. In consequence, our future experiments will focus on cell-matrix interactions concerning, for example, cardiomyocytes.
Adhesion of hMSCs and hiPSCs on bioactive alginates
The conducted experiments with hMSCs demonstrated the ability to produce bioactive alginate surfaces for adult stem cells. Whereas hMSCs are per definition plastic-adherent (Dominici et al. 2006) or attach and spread on collagen I surfaces, a more sophisticated extracellular matrix (ECM) composition is necessary for the adhesion of hiPSCs. The protein mixture Matrigel consists of many different proteins, and hence, direct immobilization is challenging. We were able to verify our hypothesis that the introduction of protein-interaction groups in alginate hydrogels is an elegant and universal technique for protein coating as used in human stem cell biology (Beers et al. 2012). After coupling of a linker molecule, the alginate surface can be coated similar to standard petri dishes. To the best of our knowledge, the covalent coupling of a linker with subsequent Matrigel coating for cultivation of hiPSCs was never performed before our study. In addition, data from our most recent experiments (data not shown) revealed that hMSCs are in fact able to interact directly with alginates modified with the linker molecule most likely via increased adsorption of proteins, such as fibronectin present in serum-containing culture media (Grinnell and Feld 1982; Wilson et al. 2005).
In our experiments, hiPSCs revealed excellent attachment and adhesion on linker-modified alginates coated with Matrigel (see Fig. 5c, d). In contrast, direct coupling of Matrigel did not lead to reliable bioactive planar alginates (see Fig. 5b, d). The chemical composition of this protein mixture may serve as one explanation for this finding. Matrigel consists of more than 1000 different proteins (Hughes et al. 2010). Since the activation of the hydrogel’s surface is conducted at low pH, a precipitation/denaturation of proteins might be possible. The overall efficiency of the modification process might be affected. Despite the excellent adhesion of the cells, the proliferation on A-LKR-MG (see Fig. 5e) is reduced compared to the standard polystyrene petri dish coated with Matrigel (T-MG). The reduced different proliferation rates can arise due to different mechanical properties of the studied surfaces. While polystyrene is stiff, alginate provides a soft surface. Since cells are sensitive to the stiffness of their underlying substrate (Discher et al. 2005) until a depth of roughly 5 μm (Buxboim et al. 2010), a direct influence on proliferation can be expected.
Furthermore, our data confirm our hypothesis that alginate hydrogels modified with the linker can be coated with Matrigel and, in consequence, mediate cell-matrix interactions. In our opinion, the prevalent molecular mechanisms refer to the increased adsorption of proteins from the Matrigel solution. We conclude that the modification of alginate hydrogels with a linker leads to chemical properties of the surface, which are similar to standard tissue culture-treated polystyrene (concerning wettability and protein adsorption), and thus can easily integrated in standard monolayer cell culture.
Adherent suspension culture of hMSCs on microcarriers
The variations in the cell attachment of small UHV-alginate microcarriers can be explained by variations in the microcarrier diameter caused by the production procedure. The formation of small alginate microcarriers was achieved by adjusting an alginate spray with large and small droplets. Though this heterogeneous distribution is not optimal for technical processes, it can serve as an interesting tool for the cultivation of cells on microcarriers, since this randomness is an increased degree of freedom in a macroscopic scale similar to the random organization of ECM fibers in cellular environments (van Loon et al. 2013).
The differences concerning the agglomeration behavior between the large and small alginate microcarriers as well as Cytodex 1 and 3 microcarriers can be explained by the cultivation setup in the used suspension bioreactor. The complex process of microcarrier-cell aggregation depends on the agitation rate or the inoculated cell density; however, this process is not yet completely understood (Ferrari et al. 2012). For cell-based models, agglomerated cell-microcarrier systems can be disadvantageous for long-term cultivation of anchorage-dependent cell lines. In large agglomerated systems, the supply of cells with nutrients and oxygen can be limited, and in consequence, a decrease of viability can be expected. In bioreactors, the area of adjacent microcarriers, interacting over cell-cell contacts, is critical, since the exposition to high shear stress during cultivation causes cell death. Furthermore, the increasing agglomeration of microcarriers causes an adoption of agitation speed to avoid sedimentation of agglomerates (Cherry and Papoutsakis 1988).
The large alginate microcarriers reveal the potential ability to serve as an excellent system for cultivation of hMSCs in rotating bioreactors, since their dimension allows adhesion and spreading of larger cells like hMSCs. Obviously, on large alginate microcarriers, a larger amount of cells is able to grow, which can be crucial if a certain number of cell-cell contacts are required for efficient expansion or functionality. In contrast to rigid commercial available microcarrier systems, UHV-alginate microcarriers can be compressed by cellular tension and thus are more cell-responsible and comparable to in vivo environments. In conclusion, our experiments proved that covalent binding of individual proteins to alginate and subsequent cultivation of multipotent stem cells are possible.
This method is not only applicable for the different 2D and 3D cultivation methods of multipotent stem cells, but potentially likewise transferable to the newly developed xeno-free cultivation of pluripotent stem cells on vitronectin or laminin. The development of novel biomimetic cellular environments for differentiation and/or disease modeling indicates the greatest potential using both our alginate technology and the presented bioactivation procedure.
References
Asthana A, Kisaalita WS (2012) Biophysical microenvironment and 3D culture physiological relevance. Drug Discov Today 18:533–540
Beers J, Gulbranson DR, George N et al (2012) Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat Protoc 7:2029–2040
Buxboim A, Rajagopal K, Brown AEX, Discher DE (2010) How deeply cells feel: methods for thin gels. J Phys Condens Matter 22:194116
Chen A, Reuveny S, Oh S (2013) Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotech Adv 31:1032–1046
Chen G, Hou Z, Gulbranson DR, Thomson JA (2010) Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 7:240–248
Cherry RS, Papoutsakis ET (1988) Physical mechanisms of cell damage in microcarrier cell culture bioreactors. Biotechnol Bioeng 32:1001–1014
Curl CL, Bellair CJ, Harris PJ, Allman BE, Roberts A, Nugent KA, Delbridge LM (2004) Quantitative phase microscopy: a new tool for investigating the structure and function of unstained live cells. Clin Exp Pharmacol Physiol 31:896–901
Dalheim M, Vanacker J, Najmi MA, Aachmann FL, Strand BL, Christensen BE (2016) Efficient functionalization of alginate biomaterials. Biomaterials 80:146–156
de Peppo GM, Marolt D (2013) Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors. Stem Cell Res Ther 4:106. doi:10.1186/scrt317
Discher DE, Janmey P, Wang Y-L (2005) Tissue cells feel and respond to the stiffness of their substrate. Science 310:1139–1143
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Dj P, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Draget KI, Smidsrød O, Skjåk-Bræk G (2005) Alginates from algae. In: Steinbüchel A, Rhee SK (eds) Polysaccharides and polyamides in the food industry. Wiley-VCH, Weinheim, pp 1–30
Duvivier-Kali VF, Omer A, Parent RJ, O’Neil JJ, Weir GC (2001) Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50:1698–1705
Ebert AD, Liang P, Wu JC (2012) Induced pluripotent stem cells as a disease modeling and drug screening platform. J Cardiovasc Pharmacol 60:408–416
Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126:677–689
Fadeev AG, Melkoumian Z (2011) Synthetic surfaces for human embryonic stem cell culture. In: Kallos M (ed) Embryonic stem cells—basic biology to bioengineering. InTech, pp 89–104
Fan Y, Wu J, Ashok P, Hsiung M, Tzanakakis ES (2014) Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges. Stem Cell Rev Rep 11:96–109
Ferrari C, Balandras F, Guedon E, Olmos E, Chevalot I, Marc A (2012) Limiting cell aggregation during mesenchymal stem cell expansion on microcarriers. Biotechnol Prog 28:780–787
Fertah M, Belfkira A, Dahmane EM, Taourirte M, Brouillette F (2014) Extraction and characterization of sodium alginate from Moroccan Laminaria digitata brown seaweed. Arab J Chem. doi:10.1016/j.arabjc.2014.05.003
Frauenschuh S, Reichmann E, Ibold Y, Goetz PM, Sittinger M, Ringe J (2007) A microcarrier-based cultivation system for expansion of primary mesenchymal stem cells. Biotechnol Prog 23:187–193
Gattazzo F, Urciuolo A, Bonaldo P (2014) Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim Biophys Acta Gen Subj 1840:2506–2519
Ghaemi SR, Harding FJ, Delalat B, Gronthos S, Voelcker NH (2013) Exploring the mesenchymal stem cell niche using high throughput screening. Biomaterials 34:7601–7615
Goh TK-P, Zhang Z-Y, Chen AK-L, Reuveny S, Choolani M, Chan JK, Oh SK (2013) Microcarrier culture for efficient expansion and osteogenic differentiation of human fetal mesenchymal stem cells. Biores Open Access 2:84–97
Grinnell F, Feld MK (1982) Fibronectin adsorption on hydrophilic and hydrophobic surfaces detected by antibody-binding and analyzed during cell-adhesion in serum-containing medium. J Biol Chem 257:4888–4893
Gröhn P, Klöck G, Zimmermann U (1997) Collagen-coated Ba2+-alginate microcarriers for the culture of anchorage-dependent mammalian cells. BioTechniques 22:970–975
Gunaseeli I, Doss M, Antzelevitch C, Hescheler J, Sachinidis A (2010) Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. Curr Med Chem 17:759–766
Hughes CS, Postovit LM, Lajoie GA (2010) Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10:1886–1890
Ingber DE, Mow VC, Butler D, Niklason L, Huard J, Mao J, Yannas I, Kaplan D, Vunjak-Novakovic G (2006) Tissue engineering and developmental biology: going biomimetic. Tissue Eng 12:3265–3283
Jeong SI, Krebs MD, Bonino CA, Khan SA, Alsberg E (2010) Electrospun alginate nanofibers with controlled cell adhesion for tissue engineering. Macromol Biosci 10:934–943
Jork A, Thürmer F, Cramer H, Zimmermann G, Gessner P, Hämel K, Hofmann G, Kuttler B, Hahn HJ, Josimovic-Alasevic O, Fritsch KG, Zimmermann U (2000) Biocompatible alginate from freshly collected Laminaria pallida for implantation. Appl Microbiol Biotechnol 53:224–229
Kaplan DL, Moon RT, Vunjak-Novakovic G (2005) It takes a village to grow a tissue. Nat Biotechnol 23:1237–1239
Kempf H, Kropp C, Olmer R, Martin U, Zweigert R (2015) Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc 10:1345–1361
Kimlin L, Kassis J, Virador V (2013) 3D in vitro tissue models and their potential for drug screening. Expert Opin Drug Discov 8:1455–1466
Kong D, Chen M, Gentz R, Zhang J (1999) Cell growth and protein formation on various microcarriers. Cytotechnology 29:151–158
Krawetz RJ, Li X, Rancourt DE (2009) Human embryonic stem cells: caught between a ROCK inhibitor and a hard place. BioEssays 31:336–343
Kurosawa H (2012) Application of Rho-associated protein kinase (ROCK) inhibitor to human pluripotent stem cells. J Biosci Bioeng 114:577–581
Lancaster MA, Knoblich JA (2014) Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc 9:2329–2340
Lee G, Chambers SM, Tomishima MJ, Studer L (2010) Derivation of neural crest cells from human pluripotent stem cells. Nat Protoc 5:688–701
Liu CC, Lian WC, Butler M, Wu SC (2007) High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 25:19–24
Machida-Sano I, Hirakawa M, Matsumoto H, Kamada M, Ogawa S, Satoh N, Namiki H (2014) Surface characteristics determining the cell compatibility of ionically cross-linked alginate gels. Biomed Mater 9:25007
Machida-Sano I, Matsuda Y, Namiki H (2009) In vitro adhesion of human dermal fibroblasts on iron cross-linked alginate films. Biomed Mater 4:25008
Malpique R, Osório LM, Ferreira DS, Ehrhart F, Brito C, Zimmermann H, Alves PM (2010) Alginate encapsulation as a novel strategy for the cryopreservation of neurospheres. Tissue Eng Part C Methods 16:965–977
Mettler E, Trenkler A, Feilen PJ, Wiegand F, Fottner C, Ehrhart F, Zimmermann H, Hwang YH, Lee DY, Fischer S, Schreiber LM, Weber MM (2013) Magnetic separation of encapsulated islet cells labeled with superparamagnetic iron oxide nano particles. Xenotransplantation 20:219–226
Murphy CM, O’Brien FJ, Little DG, Schindeler A (2013) Cell-scaffold interactions in the bone tissue engineering triad. Eur Cell Mater 26:120–132
Neufeld T, Ludwig B, Barkai U et al (2013) The efficacy of an immunoisolating membrane system for islet xenotransplantation in minipigs. PLoS One 8:e70150
Nienow AW, Hewitt CJ, Heathman TRJ, Glyn VAM, Fonte GN, Hanga MP, Coopman K, Rafiq QA (2016) Agitation conditions for the culture and detachment of hMSCs from microcarriers in multiple bioreactor platforms. Biochem Eng J 108:24–29
Ponce S, Orive G, Hernández R, Gascón AR, Pedraz JL, de Haan BJ, Faas MM, Mathieu HJ, de Vos P (2006) Chemistry and the biological response against immunoisolating alginate—polycation capsules of different composition. Biomaterials 27:4831–4839
Prestwich GD (2007) Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J Cell Biochem 101:1370–1383
Rafiq QA, Brosnan KM, Coopman K, Nienow AW, Hewitt CJ (2013) Culture of human mesenchymal stem cells on microcarriers in a 5 l stirred-tank bioreactor. Biotechnol Lett 35:1233–1245
Re’em T, Tsur-Gang O, Cohen S (2010) The effect of immobilized RGD peptide in macroporous alginate scaffolds on TGFβ1-induced chondrogenesis of human mesenchymal stem cells. Biomaterials 31:6746–6755
Rodríguez Patino JM, Pilosof AMR (2011) Protein-polysaccharide interactions at fluid interfaces. Food Hydrocoll 25:1925–1937
Rowley JA, Madlambayan G, Mooney DJ (1999) Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20:45–53
Saha K, Mei Y, Reisterer CM, Pyzocha NK, Yang J, Muffat J, Davies MC, Alexander MR, Langer R, Anderson DG, Jaenisch R (2011) Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci U S A 108:18714–18719
Sang L, Luo D, Xu S, Wang X, Li X (2011) Fabrication and evaluation of biomimetic scaffolds by using collagen—alginate fibrillar gels for potential tissue engineering applications. Mater Sci Eng C 31:262–271
Schneider S, Feilen PJ, Brunnenmeier F, Minnemann T, Zimmermann H, Zimmermann U, Weber MM (2005) Long-term graft function of adult rat and human islets encapsulated in novel alginate-based microcapsules after transplantation in immunocompetent diabetic mice. Diabetes 54:687–693
Sheridan SD, Surampudi V, Rao RR (2012) Analysis of embryoid bodies derived from human induced pluripotent stem cells as a means to assess pluripotency. Stem Cells Int 2012:738910
Smidsrød O, Skjåk-Bræk G (1990) Alginate as immobilization matrix for cells. Trends Biotechnol 8:71–78
Storz H, Müller KJ, Ehrhart F, Gómez I, Shirley SG, Gessner P, Zimmermann G, Weyand E, Sukhorukov VL, Forst T, Weber MM, Zimmermann H, Kulicke W-M, Zimmermann U (2009) Physicochemical features of ultra-high viscosity alginates. Carbohydr Res 344:985–995
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861–872
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663–676
Terazono H, Kim H, Hayashi M, Hattori A, Nomura F, Kaneko T, Yasuda K (2012) A non-destructive culturing and cell sorting method for cardiomyocytes and neurons using a double alginate layer. PLoS One 7:e42485
van Loon SLM, Smits A, Driessen-Mol A, Baaijens FPT, Bouten CVC (2013) The immune response in in situ tissue engineering of aortic heart valves. In: Aikawa E (ed) Calcific aortic valve disease. Riejeka, InTech, pp 207–245
van Schilfgaarde R, de Vos P (1999) Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets. J Mol Med 77:199–205
Van Wezel AL (1967) Growth of cell-strains and primary cells on micro-carriers in homogeneous culture. Nature 216:64–65
Watt FM, Huck WTS (2013) Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol 14:467–473
Weber C, Pohl S, Pörtner R, Wallrapp C, Kassem M, Geigle P, Czermak P (2007) Expansion and harvesting of hMSC-TERT. Open Biomed Eng J 1:38–46
Wilson CJ, Clegg RE, Leavesley DI, Pearcy MJ (2005) Mediation of biomaterial-cell interactions by adsorbed proteins: a review. Tissue Eng 11:1–18
Zimmermann H, Shirley SG, Zimmermann U (2007a) Alginate-based encapsulation of cells: past, present, and future. Curr Diab Rep 7:314–320
Zimmermann H, Wählisch F, Baier C et al (2007b) Physical and biological properties of barium cross-linked alginate membranes. Biomaterials 28:1327–1345
Zimmermann H, Zimmermann D, Reuss R et al (2005) Towards a medically approved technology for alginate-based microcapsules allowing long-term immunoisolated transplantation. J Mater Sci Mater Med 16:491–501
Acknowledgements
This work was supported by a grant from the German Federal Ministry of Education (BMBF), given to H. Z. (grant no. 031581B). We would like to thank Dr. Sabine C. Mueller for careful proofreading.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Gepp, M.M., Fischer, B., Schulz, A. et al. Bioactive surfaces from seaweed-derived alginates for the cultivation of human stem cells. J Appl Phycol 29, 2451–2461 (2017). https://doi.org/10.1007/s10811-017-1130-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10811-017-1130-6